Pure Global

Clinical Trial - Trial jRCTs041220085

Access comprehensive clinical trial information for jRCTs041220085 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruitment Completed. The study focuses on colorectal cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
jRCTs041220085
Recruitment Completed
Trial Details
Japan Registry Clinical Trial โ€ข jRCTs041220085
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Phase2 study of intrapatient dose escalation of biweekly trifluridine/tipiracil + bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (E BiTS study)

Study Focus

colorectal cancer

Interventional

Sponsor & Location

Timeline & Enrollment

N/A

N/A

N/A

ICD-10 Classifications

Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon

Data Source

Japan Registry Clinical Trial

jRCTs041220085

Non-Device Trial